Related Experiment Video
Updated: Jun 8, 2026
03:22
Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
Published on: November 10, 2023
Pleuroperitoneal shunting for intractable cardiogenic pleural effusions
Takayoshi Kato1, Yukio Umeda, Ken-Ichiro Azuma
1Department of Cardiovascular Surgery, Gifu Municipal Hospital, Gifu, Japan. tkato@heart-center.or.jp
Asian Cardiovascular & Thoracic Annals
|October 16, 2010
Summary
Pleuroperitoneal shunting effectively managed intractable pleural effusions in a patient with post-infarction ventricular septal defect. This intervention facilitated successful weaning from mechanical ventilation after other therapies failed.
Area of Science:
- Cardiovascular Surgery
- Thoracic Surgery
- Critical Care Medicine
Background:
- Post-infarction ventricular septal defect (VSD) repair is a complex cardiac surgical procedure.
- Intractable pleural effusions can complicate postoperative recovery, leading to prolonged mechanical ventilation.
- Failure of conservative management necessitates alternative therapeutic strategies.
Observation:
- A 72-year-old male patient developed bilateral pleural effusions following VSD repair.
- The patient required prolonged positive-pressure-assisted ventilation due to the effusions.
- Conservative treatments for the pleural effusions proved ineffective.
Findings:
- Pleuroperitoneal shunting was implemented as a therapeutic intervention.
- Following the shunting procedure, the patient was successfully weaned from the respirator.
- This indicates the efficacy of pleuroperitoneal shunting in managing refractory pleural effusions post-cardiac surgery.
Implications:
- Pleuroperitoneal shunting presents a viable treatment option for managing intractable pleural effusions in the context of complex cardiac surgery.
- This approach can potentially reduce the duration of mechanical ventilation and improve patient outcomes.
- Further research may explore the broader application of shunting procedures in similar critical care scenarios.
Related Concept Videos
01:28Pleural Effusion II: Symptoms and Management
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
01:25Pleural Effusion I: Introduction
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
01:17Pericarditis III: Medical Management
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:27Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
01:13Pleura of the Lungs
The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...